Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tisdale

Showing results (11-20 of 307) with videos related to

Pageof 31
Sort By:
Carbohydrate Research|August 1, 1971
1,2-anhydro-6-O-methanesulphonyl-D-mannitolM J Tisdale
Biochemical and Biophysical Research Communications|February 17, 1975
Inhibition of cyclic adenosine 3',5'-monophosphate phosphodiesterase from Walker carcinoma by ascorbic and dehydroascorbic acidsM J Tisdale
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|March 25, 2006
Clinical anticachexia treatmentsMichael J Tisdale
Current Opinion in Supportive and Palliative Care|August 8, 2008
Is there a common mechanism linking muscle wasting in various disease types?Michael J Tisdale
Physiological Reviews|April 4, 2009
Mechanisms of cancer cachexiaMichael J Tisdale
Methods in Enzymology|February 14, 2006
Rab2 purification and interaction with protein kinase C iota/lambda and glyceraldehyde-3-phosphate dehydrogenaseEllen J Tisdale
Nutrition (Burbank, Los Angeles County, Calif.)|January 1, 1996
Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexiaM J Tisdale
Chemico-Biological Interactions|July 1, 1977
Inhibition of prostaglandin synthetase by anti-tumour agentsM J Tisdale
Biochimica Et Biophysica Acta|July 27, 1975
Characterisation of cyclic adenosine 3':5'-monophosphate phospodiesterase from Walker carcinoma sensitive and resistant to bifunctional alkylating agentsM J Tisdale
Molecular Biology of the Cell|June 8, 1999
A Rab2 mutant with impaired GTPase activity stimulates vesicle formation from pre-Golgi intermediatesE J Tisdale
Pageof 31

Showing results (11-20 of 307) with videos related to

Sort By:
Pageof 31
Carbohydrate Research|August 1, 1971
1,2-anhydro-6-O-methanesulphonyl-D-mannitolM J Tisdale
Biochemical and Biophysical Research Communications|February 17, 1975
Inhibition of cyclic adenosine 3',5'-monophosphate phosphodiesterase from Walker carcinoma by ascorbic and dehydroascorbic acidsM J Tisdale
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|March 25, 2006
Clinical anticachexia treatmentsMichael J Tisdale
Current Opinion in Supportive and Palliative Care|August 8, 2008
Is there a common mechanism linking muscle wasting in various disease types?Michael J Tisdale
Physiological Reviews|April 4, 2009
Mechanisms of cancer cachexiaMichael J Tisdale
Methods in Enzymology|February 14, 2006
Rab2 purification and interaction with protein kinase C iota/lambda and glyceraldehyde-3-phosphate dehydrogenaseEllen J Tisdale
Nutrition (Burbank, Los Angeles County, Calif.)|January 1, 1996
Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexiaM J Tisdale
Chemico-Biological Interactions|July 1, 1977
Inhibition of prostaglandin synthetase by anti-tumour agentsM J Tisdale
Biochimica Et Biophysica Acta|July 27, 1975
Characterisation of cyclic adenosine 3':5'-monophosphate phospodiesterase from Walker carcinoma sensitive and resistant to bifunctional alkylating agentsM J Tisdale
Molecular Biology of the Cell|June 8, 1999
A Rab2 mutant with impaired GTPase activity stimulates vesicle formation from pre-Golgi intermediatesE J Tisdale
Pageof 31